Slingshot Insights

Catalyst

Slingshot members are tracking this event:

Largest Breast Cancer Study of its Kind Suggests Several New Potential Drug Targets and Combinations; results will be seized on by labs worldwide to identify new drug candidates and pinpoint mechanisms by which cancer cells resist treatment

Source Link:: http://www.prnewswire.com/news-releases/largest-breast-cancer-study-of-its-kind-suggests-several-new-potential-drug-targets-and-combinations-300205091.html

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies

Importance

High

Medium

Low

Impact on Stocks

NVS

Community voting in process

RHHBY

Community voting in process

SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Clinical Data •We screened 77 breast cancer lines using a genome-wide pooled shRNA library •We developed an algorithm (siMEM) to improve identification of context-dependent genes •Integrating screen results with genomic data reveals potential “drivers” •BRD4 is essential for luminal cancer, and mutant PIK3CA confers BET-I resistance

http://www.cell.com/...

Slingshot Insights Explained

JOIN FOR FREE TODAY

Catalyst Date

Occurred on:

Jan 14, 2016

Related Projects

Don’t see a project related to the catalyst you care about?

Related Keywords Breast Cancer, Study, Drug Combinations